EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
BioAge Labs, Inc. (BIOA) had EBIT Margin of -923.42% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$3.08M |
|
$-25.94M |
|
-- |
|
$3.08M |
|
$31.50M |
|
$-28.42M |
|
$2.48M |
|
$-25.94M |
|
$-25.94M |
|
$-25.94M |
|
$-25.94M |
|
$-25.94M |
|
$-25.94M |
|
$-28.42M |
|
$-28.35M |
|
35.93M |
|
35.93M |
|
$-0.72 |
|
$-0.72 |
|
| Balance Sheet Financials | |
$286.79M |
|
$0.96M |
|
$8.10M |
|
$294.89M |
|
$20.14M |
|
-- |
|
$2.70M |
|
$22.84M |
|
$272.05M |
|
$272.05M |
|
$272.05M |
|
37.39M |
|
| Cash Flow Statement Financials | |
$-81.63M |
|
$-95.22M |
|
$11.47M |
|
$354.35M |
|
$188.89M |
|
$-165.46M |
|
$11.69M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.24 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
100.00% |
|
-923.42% |
|
|
EBIT Margin |
-923.42% |
-- |
|
-842.85% |
|
-842.85% |
|
$-237.09M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
4.00 |
|
22.49 |
|
-9.54% |
|
-9.54% |
|
-8.80% |
|
-9.54% |
|
$7.28 |
|
$-6.60 |
|
$-2.27 |
|